Post-stroke Cognitive Impairment Clinical Trial
Official title:
Efficacy and Safety of Edaravone Dexborneol Sublingual Tablet for Post-stroke Cognitive Impairment in Patients With Acute Ischemic Stroke: a Multicenter, Randomized, Double-blind, Placebo-controlled, Exploratory Phase II Clinical Trial.
This is a multicenter, randomized, double-blind, placebo-controlled, exploratory Phase II clinical trial. The goal of this clinical trial is to assess the safety and efficacy of edaravone dexborneol sublingual tablets for post-stroke cognitive impairment in patients with acute ischemic stroke. Participants will be required to receive 12 weeks treatment of edaravone dexborneol sublingual tablets or placebo during this study. The safety and efficacy endpoints will be compared in the patients with edaravone dexborneol sublingual tablets or placebo.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04318626 -
The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment
|
Phase 2 | |
| Completed |
NCT03519828 -
Oxidation-reduction Homeostasis in Cognitive Impairment Patients After Stroke
|
||
| Withdrawn |
NCT03202147 -
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
|
Phase 2 | |
| Recruiting |
NCT05731310 -
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
|
Early Phase 1 | |
| Recruiting |
NCT04596072 -
A Clinical Trail of Acupuncture and Herbs for Post-stroke Cogntive Impairment
|
N/A | |
| Completed |
NCT03647319 -
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Post-stroke Cognitive Impairment
|
N/A | |
| Not yet recruiting |
NCT06316557 -
High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment
|
N/A |